April 22, 2020

Dear Patient,

Thank you for entrusting your healthcare to CIS, our physicians, and staff. On April 1, 2020 the Food and Drug Administration (FDA) announced the removal of all Ranitidine (Zantac) products from the market after an investigation revealed the medication contained a contaminate that could be carcinogenic. If your medication is part of the recall, please call your local CIS office and an alternative medication will be recommended.

This contaminate has not been found in famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (Nexium), lansoprazole (Prevacid) or omeprazole (Prilosec).  Please discuss with providers alternatives for patients required to switch medications.

As always, CIS wishes to provide excellent care to you, our patients. The full press release and statement from the FDA can be viewed BY CLICKING HERE.

Thank you for your time and attention to this matter.

CIS Physicians and Staff